Sign in

CIK 0001191070 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Neuphoria Therapeutics Inc.

Sign in to watch
Ticker
NEUP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
Australia
Entity type
operating
Phone
781-439-5551
Business address
100 SUMMIT DR, BURLINGTON, MA, 01803
Former names
BIONOMICS LIMITED/FI
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. 8-K Event Other events
  4. 8-K Event Executive or director change
  5. PRE 14A Proxy Proxy Statement (Preliminary)
  6. SC 13D/A Stake Beneficial Ownership Report
  7. 8-K Event Material agreement
  8. 10-K Report Annual Report
  9. 8-K Event Delisting notice
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. EFFECT Other Notice of Effectiveness
  18. 424B3 Offering Prospectus
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. UPLOAD Other SEC-generated Letter

Page 6 of 21 · 420 filings